Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 33.82
+3.60 (11.91%)
Nov 4, 2026, 2:45 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 77.13 billion as of November 3, 2026. It is the 2,334th most valuable company in the world and the 121st biggest in Hong Kong. Its market cap has increased by 107.08% in one year.
Market Cap
77.13B
Enterprise Value
73.51B
Revenue
6.63B
Global Rank
Country Rank
#121 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 77.13B, an increase of 3,551.82%. That is a compound annual growth rate of 39.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 77.13B | 184.02% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 182.53B |
| Innovent Biologics | 138.84B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.54B |
| Sino Biopharmaceutical | 85.84B |
| Akeso | 76.70B |
| RemeGen | 51.84B |
| Biocytogen Pharmaceuticals (Beijing) | 34.89B |
| 3SBio | 33.74B |